Indegene Limited Responds to BSE Clarification on Price and Volume Movement

1 min read     Updated on 24 Mar 2026, 08:43 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Indegene Limited responded to BSE's inquiry about significant price and volume movements in its securities on March 24, 2026. The company confirmed no undisclosed material events are pending and attributed recent market movements to prevailing conditions and investor sentiment. The response was digitally signed by Company Secretary Srishti Ramesh Kaushik, reaffirming the company's commitment to transparent regulatory disclosures.

powered bylight_fuzz_icon
35910829

*this image is generated using AI for illustrative purposes only.

Indegene Limited has issued a formal response to the Bombay Stock Exchange (BSE) regarding an inquiry about significant price and volume movements in the company's securities. The clarification, dated March 24, 2026, addresses BSE's concerns under reference number L/SURV/ONL/PV/SG/ 2025-2026 / 996.

Company's Official Response

In its communication to BSE, Indegene confirmed that there is no pending information or undisclosed material event that could significantly impact the price or trading volume of the company's securities as of the date of communication. The company attributed the recent market movements and volatility to prevailing market conditions and investor sentiment rather than any specific corporate developments.

Regulatory Compliance Commitment

The company emphasized its commitment to maintaining transparent and timely disclosures in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Indegene assured that any material developments will be communicated in accordance with applicable regulatory requirements.

Communication Details

Parameter: Details
Date: March 24, 2026
Reference Number: L/SURV/ONL/PV/SG/ 2025-2026 / 996
Signatory: Srishti Ramesh Kaushik
Designation: Company Secretary and Compliance Officer
Digital Signature Time: 13:00:41 +05'30'

The response was digitally signed by Srishti Ramesh Kaushik, who serves as the Company Secretary and Compliance Officer for Indegene Limited. The communication was submitted to BSE's Phiroze Jeejeebhoy Towers office in Mumbai for official records and information purposes.

Historical Stock Returns for Indegene

1 Day5 Days1 Month6 Months1 Year5 Years
+1.73%+2.68%-4.78%-16.48%-17.92%-17.22%

What specific market conditions or sector trends might be driving the unusual trading activity in Indegene's stock?

Could upcoming quarterly earnings or business developments be influencing investor sentiment despite no formal announcements?

How might increased regulatory scrutiny from BSE affect Indegene's future disclosure practices and investor relations strategy?

Indegene Limited Board Approves Share Allotment Under RSU 2020 Plan

1 min read     Updated on 18 Mar 2026, 09:00 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Indegene Limited's Board of Directors approved resolutions on March 18, 2026, for share allotment under the RSU 2020 plan, covering both bonus and non-bonus elements. The resolutions were passed through circulation and disclosed in compliance with SEBI Regulation 30, demonstrating the company's commitment to regulatory transparency and structured employee compensation programs.

powered bylight_fuzz_icon
35393450

*this image is generated using AI for illustrative purposes only.

Indegene Limited has announced that its Board of Directors approved resolutions for share allotment under the company's RSU 2020 plan on March 18, 2026. The resolutions were passed through circulation, indicating efficient board governance processes.

Board Resolution Details

The board approved two specific resolutions related to the RSU 2020 plan implementation:

Resolution Type: Details
RSU Allotment (Non-Bonus): Share allotment under RSU 2020 plan without bonus element
RSU Allotment (Bonus): Share allotment under RSU 2020 plan with bonus element
Approval Date: March 18, 2026
Approval Method: Board circulation

Regulatory Compliance

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to disclose material events and information that could impact investor decisions. The disclosure demonstrates Indegene's commitment to maintaining transparency with stakeholders and regulatory compliance.

Corporate Governance

The resolutions were formally communicated to both major stock exchanges where Indegene shares are listed. The company secretary and compliance officer, Srishti Ramesh Kaushik, signed the disclosure document, ensuring proper authorization and documentation of the board decisions.

The RSU 2020 plan represents part of Indegene's employee compensation and retention strategy, allowing eligible employees to receive company shares as part of their remuneration package. The dual structure of bonus and non-bonus elements provides flexibility in the implementation of the employee stock option scheme.

Historical Stock Returns for Indegene

1 Day5 Days1 Month6 Months1 Year5 Years
+1.73%+2.68%-4.78%-16.48%-17.92%-17.22%

How will the RSU allotments impact Indegene's earnings per share and overall share dilution in the coming quarters?

What percentage of Indegene's total workforce is expected to benefit from the RSU 2020 plan implementation?

Could this employee retention strategy signal Indegene's preparation for increased competition in the healthcare technology sector?

More News on Indegene

1 Year Returns:-17.92%